Compile Data Set for Download or QSAR
Report error Found 140 Enz. Inhib. hit(s) with Target = 'Ubiquitin-like modifier-activating enzyme 1'
TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329882(US9663525, Compound I-090 | (rac)-((1R,2R,3S,4R)-2...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329883(US9663525, Compound I-091 | (rac)-((1R,2R,3S,4R)-4...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329886(US9663525, Compound I-094 | (rac)-((1R,2R,3S,4R)-4...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329884(US9663525, Compound I-092 | (rac)-((1R,2R,3S,4R)-4...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329885(US9663525, Compound I-093 | (rac)-((1R,2R,3S,4R)-4...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329874(US9663525, Compound I-082 | (rac)-((1R,2R,3S,4R)-2...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329875(US9663525, Compound I-083 | (rac)-[(1R,2R,3S,4R)-4...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329873(US9663525, Compound I-081 | (rac)-((1R,2R,3S,4R)-4...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329878(US9663525, Compound I-086 | (rac)-((1R,2R,3S,4R)-4...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329879(US9663525, Compound I-087 | (rac)-((1R,2R,3S,4R)-2...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329876(US9663525, Compound I-084 | (rac)-((1R,2R,3S,4R)-4...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329877(US9663525, Compound I-085 | (rac)-((1R,2R,3S,4R)-2...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329898(US9663525, Compound I-106 | (s.e.)-((1R,2R,3S,4R)-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329899(US9663525, Compound I-107 | (s.e.)-((1R,2R,3S,4R)-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329896(US9663525, Compound I-104 | (s.e.)-((1R,2R,3S,4R)-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329889(US9663525, Compound I-097 | (rac)-((1R,2R,3S,4R)-4...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329902(US9663525, Compound I-110 | (s.e.)-((1R,2R,3S,4R)-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329903(US9663525, Compound I-111 | (s.e.)-((1R,2R,3S,4R)-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329900(US9663525, Compound I-108 | (s.e.)-[(1R,2R,3S,4R)-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329901(US9663525, Compound I-109 | (s.e.)-((1R,2R,3S,4R)-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329794(US9663525, Compound I-002 | US9663525, Compound I-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329891(US9663525, Compound I-099 | (rac)-rel-5-[7-({(1R,2...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329888(US9663525, Compound I-096 | (rac)-methyl rel-5-[7-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329889(US9663525, Compound I-097 | (rac)-((1R,2R,3S,4R)-4...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329858(US9663525, Compound I-066 | US9663525, Compound I-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329802(US9663525, Compound I-010 | US9663525, Compound I-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329892(US9663525, Compound I-100 | (s.e.)-((1R,2R,3S,4R)-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329836(US9663525, Compound I-044 | US9663525, Compound I-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329914(US9663525, Compound I-122 | (rac)-[(1R,2R,3S,4R)-2...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329915(US9663525, Compound I-123 | (rac)-{(1R,2R,3S,4R)-4...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329912(US9663525, Compound I-120 | (s.e.)-((1R,2R,3S,4R)-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329913(US9663525, Compound I-121 | (rac)-((1R,2R,3S,4R)-2...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329906(US9663525, Compound I-114 | (s.e.)-((1R,2R,3S,4R)-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329907(US9663525, Compound I-115 | (s.e.)-((1R,2R,3S,4R)-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329904(US9663525, Compound I-112 | (s.e.)-((1R,2R,3S,4R)-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329905(US9663525, Compound I-113 | (s.e.)-((1R,2R,3S,4R)-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329910(US9663525, Compound I-118 | (s.e.)-((1R,2R,3S,4R)-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329911(US9663525, Compound I-119 | (s.e.)-((1R,2R,3S,4R)-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329908(US9663525, Compound I-116 | (s.e.)-((1R,2R,3S,4R)-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329802(US9663525, Compound I-010 | US9663525, Compound I-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329807(US9663525, Compound I-015 | US9663525, Compound I-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329794(US9663525, Compound I-002 | US9663525, Compound I-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329795(US9663525, Compound I-003 | (rac)((1R,2R,3S,4R)-4-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329799(US9663525, Compound I-007 | (rac)-((1R,2R,3S,4R)-2...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329797(US9663525, Compound I-005 | (rac)-((1R,2R,3S,4R)-4...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329818(US9663525, Compound I-026 | (rac)-((1R,2R,3S,4R)-4...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329819(US9663525, Compound I-027 | (rac)-((1R,2R,3S,4R)-2...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329816(US9663525, Compound I-024 | (rac)-((1R,2R,3S,4R)-4...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329822(US9663525, Compound I-030 | (rac)-((1R,2R,3S,4R)-4...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329823(US9663525, Compound I-031 | (rac)-[(1R,2R,3S,4R)-2...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

Displayed 1 to 50 (of 140 total ) | Next | Last >>
Jump to: